BOD Australia eyes best day in 3-mths on collaboration with UK-based Drug Science

Bod Science

18/03/2021 01:05

** Shares of BOD Australia  BDA.AX  rise as much as 4.6% to
A$0.570, their highest since Dec 16
    ** The medicinal cannabis firm signs collaboration agreement
with Drug Science, UK-based independent scientific body on drugs
 urn:newsml:reuters.com:*:nASX8yJgc0
    ** Agreement to progress study on efficacy of MediCabilis in
managing symptoms associated with the long-term impact of
COVID-19 
    ** Co says MediCabilis is currently prescribed for patients
with chronic pain, anxiety and sleep disorders
    ** Stock posts fifth consecutive session of gains 
    ** More than 1.1 mln shares change hands, vs the 30-day
average volume of about 319,000 shares
    ** Stock has risen 11.2% this year as of last close
    
  

 (Reporting by Harish Sridharan in Bengaluru)
 ((harish.sridharan@thomsonreuters.com))